News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Nicholas Hornstein: More ctDNA data than you can shake a stick at GI25
Nicholas Hornstein/X
Jan 23, 2025, 15:43

Nicholas Hornstein: More ctDNA data than you can shake a stick at GI25

Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, shared a post on X:

“More ctDNA data than you can shake a stick at GI25.

Early conversion of ctDNA status is a good predictor of patients appropriate for watch and wait in rectal cancer (not just 1, but 2 studies).

α-CORRECT with a brutal sensitivity of only 48% in stage III CRC.

ctDNA in BTC:

Correlation of mid-chemoradiation ctDNA results and clinical complete response to total neoadjuvant therapy (TNT) for locally advanced rectal adenocarcinoma

Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial (CCTG CO.28)

Circulating tumor DNA as a marker of recurrence risk in stage III colorectal cancer: The α-CORRECT study

Utilization of circulating tumor DNA (ctDNA) testing in biliary tract cancers“

More posts featuring Nicholas Hornstein.

Biliary tract cancers cancer ctDNA II NEO trial Nicholas Hornstein OncoDaily Oncology rectal cancer The α-CORRECT study TNT tumour
Special Coverage
Insight
Jan 23, 2025, 15:43
Nicholas Hornstein: More ctDNA data than you can shake a stick at GI25
Science
Jan 23, 2025, 15:31
Next-generation imaging for evaluation in patients with prostate cancer after biochemical recurrence
Science
Jan 23, 2025, 15:28
Summary of the intrinsic, extrinsic and systemic factors developing ‘cold’ tumors
Blog
Jan 23, 2025, 15:27
Daneen Sekoni: Looking for a Manager, Policy and Advocacy at Cancer Support Community
Insight
Jan 23, 2025, 15:24
International BPDCN Day 2025: Advancing Awareness, Research, and Hope for a Rare Hematologic Cancer
Science
Jan 23, 2025, 15:24
Damir Ivanković: Enablers and barriers in implementing global cancer care efficiency metrics
Blog
Jan 23, 2025, 15:13
The 4th edition of Pediatric Radiation Oncology (Virtual) Course (PedROC 4.0) - The Dorcas Cancer Foundation
Blog
Jan 23, 2025, 15:02
Sachin H. Jain: The healthcare industry’s silent complicity in the face of massive dysfunction
Blog
Jan 23, 2025, 14:53
The PAINT Cancer Awareness and Hope event hosted by Cancer Fight Tanzania
Insight
Jan 23, 2025, 14:52
Debate Highlights Presented by Matti Aapro: Should All HR+/HER2- Metastatic Breast Cancer Patients Receive CDK4/6 Inhibitors in the First Line?
Insight
Jan 23, 2025, 14:43
Prof. Joseph Gligorov at BGICC 2025: Should All HR+/HER2- Metastatic Breast Cancer Patients Receive CDK4/6 Inhibitors in the First Line?
Blog
Jan 23, 2025, 14:43
AACR Forum on Exploring a New Generation of Patient-Centric Cancer Clinical Trials